We investigated the effect of ketamine on inositol 1,4,5-trisphosphate (IP3) formation in rat cardiomyocytes. After the addition of 1 mol/L ketamine, IP3 production in the presence of 0.5, 1, 5, 10, and 30 mmol/L Ca 2ϩ significantly decreased from 537.1 Ϯ 8.3, 590.7 Ϯ 12.9, 690.6 Ϯ 7.9, 754.8 Ϯ 12.5, and 823.7 Ϯ 15.2 pmol/mg protein to 467.0 Ϯ 8.3, 483.8 Ϯ 11.0, 512.6 Ϯ 21.3, 612.1 Ϯ 16.9, and 652.6 Ϯ 17.3 pmol/mg protein, respectively. When exposed to TMB-8 (a intracellular calcium inhibitor), IP3 production decreased significantly from 347.2 Ϯ 27.3 to 283.8 Ϯ 20.4 pmol/mg protein in the presence of 1 mol/L ketamine, but A23187, which increases intracellular calcium, did not affect the inhibition of IP3 production by ketamine. These results demonstrate that ketamine decreases IP3 formation through inhibition of the calcium ion-sensing receptor and that IP3 formation reduced by ketamine is not affected by the alteration of intracellular calcium. Implications: Ketamine has a negative inotropic effect in isolated cardiomyocytes. The negative inotropic effect was associated with a decrease in inositol 1,4,5-trisphosphate production, and the inhibitory action was enhanced depending on the concentration of extracellular Ca 2ϩ .
intracellular calcium, did not affect the inhibition of IP3 production by ketamine. These results demonstrate that ketamine decreases IP3 formation through inhibition of the calcium ion-sensing receptor and that IP3 formation reduced by ketamine is not affected by the alteration of intracellular calcium. Implications: Ketamine has a negative inotropic effect in isolated cardiomyocytes. The negative inotropic effect was associated with a decrease in inositol 1,4,5-trisphosphate production, and the inhibitory action was enhanced depending on the concentration of extracellular Ca M yocardial contractility is clinically enhanced by ketamine as a result of sympathomimetic stimulation through the central nervous system and activation of the baroreceptor and the inhibition of neuronal uptake of catecholamine (1) . However, ketamine is reported to have a negative inotropic effect in isolated cardiomyocytes (2) . Waxman et al. (3) showed that ketamine has a direct depressing effect on myocardial contractility in the absence of sympathetic stimulation. The negative inotropic effect with ketamine could be caused by a decrease in Ca 2ϩ release from intracellular stores and an interference with Ca 2ϩ influx through a voltage-dependent Ca 2ϩ channel (5) . Bradykinin (BK) is an important mediator of the physiological response to injury, pain, and trauma (6) and simultaneously has a positive inotropic effect on the heart. The hormone is a mediator of the protection of myocardium by angiotensin-converting enzyme (ACE) inhibitors (7) . The ACE inhibitor inhibits the degradation of BK and potentiates the pharmacological action of BK. The stimulation of BK receptors results in increased inositol 1,4,5-trisphosphate (IP3)
production. BK has been demonstrated to act on G-protein-coupled receptors to activate phospholipase C (PLC) and to stimulate the rapid formation of IP3, which leads to an increase in intracellular Ca 2ϩ from sarcoplasmic reticulum (SR) and regulates myocardial contraction (8) . G protein in isolated cardiac membrane preparations has been shown to increase IP3 production depending on the concentration of extracellular Ca 2ϩ at physiological ranges (9) through the Ca 2ϩ -sensing receptor, which links the PLC and controls phosphoinositide turnover and intracellular calcium release (10) . The extracellular Ca 2ϩ concentration may thus play a regulatory role in receptormediated phosphoinositide turnover (11) .
We designed this study to investigate the effects of ketamine on phosphatidyl inositol turnover and the process of calcium metabolism in neonatal rat cardiomyocytes.
Methods
This study was approved by our institutional animal committee. Neonatal rats were anesthetized with sevoflurane and killed by cervical dislocation. Using an aseptic technique, we isolated myocytes according to the method of Sadoshima et al. (12) . The hearts were rapidly removed and placed in ice-cold Ca 2ϩ -and Mg 2ϩ -free phosphate-buffered saline (PBS) containing 40 U/mL sodium heparin, 4 mmol/L glucose, and 25 mmol/L HEPES. The hearts were washed with 4 L of PBS. The atria and ventricles were divided and kept in ice-cold modified Eagle's medium and PBS, respectively. The ventricles were minced with scissors into 1-to 3-mm 3 fragments, which were then washed with PBS by gently stirring in a 37°C water-jacketed Erlenmeyer flask for 10 min. The tissue was then enzymatically digested five times for 10 min each with 10 mL of PBS containing 0.1% trypsin, 0.1% collagenase (type 5), 15 g/mL deoxyribonuclease 1, and 1% chicken serum. The liberated cells were collected by centrifugation at 200g and resuspended in PBS containing calf serum. The pooled and washed cells were plated in T-75 cell culture flasks in medium 199 (M199)-supplemented media (containing Earle's balanced salts, 5% horse serum, 3 mmol/L pyruvic acid, MEN vitamins, 1 g/mL insulin, 1 g/mL transferrin, 10 ng/mL selenium, and 50 g/mL gentamicin). The nonadherent cells were harvested after incubation at 37°C for 60 min in a humidified incubator with 5% CO 2 in air. The cells were counted and resuspended in M199-supplemented media containing 0.1 mmol/L 5-bromo-2Јdeopxyuridiner to inhibit cell division and thereby control nonmyocyte cell growth. Fibroblasts were divided from cardiomyocytes. The suspension was then allocated on 0.1% gelatin-coated 25-cm 2 flasks for measurement of IP3. The culture medium was changed after 48 h with the above media and finally to serum-free medium 24 h before the cells were studied.
The study was performed 4 days after isolation of cardiomyocytes. The cultures were incubated at extracellular Ca 2ϩ concentrations of 0, 0.5, 1, 5, 10, and 30 nmol/L for 120 min before adding ketamine. Ketamine was then treated for 30 min. Cells were treated with TMB-8 (an intracellular calcium antagonist that lowers intracellular calcium by blocking the efflux of Ca 2ϩ from intracellular stores without affecting the influx), A23187 (an intracellular calcium agonist), W-7 (a calmodulin antagonist), nicardipine, and verapamil (voltage-dependent Ca 2ϩ channel blocker) at extracellular Ca 2ϩ concentrations of 0.5 mmol/L for 30 min before exposure to BK. There were eight subjects in each study.
Twenty-four hours before the experiments, the culture medium was changed to serum-free M199. After BK was added for 20 s, the reaction was stopped by aspiration of the media and addition of 5 mL of icecold 1 mol/L trichloroacetic acid (TCA) for each 1 mg of cells. The acid extract was homogenized and centrifuged at 0 -4°C for 10 min at 1000g. TCA was removed from the extracts by adding 2 mL of a mixture of 3 vol of 1,1,2-trichloro-1,2,2-trifluoroethane plus 1 vol of trioctylamine for each 1 mL of TCA extract. The IP3 content in the aqueous top layer was determined by using a radioreceptor assay kit (NEN Research Products-Du Pont, Boston, MA).
Protein concentrations were determined by using the method of Bradford (13) using bovine serum albumin as standard.
BK, TMB-8, A23187, nicardipine, verapamil, W7, cell culture medium, supplements, and all chemicals were purchased from Sigma Chemical Company (St. Louis, MO).
Data are expressed as mean ϩ sem. Repeatedmeasures analysis of variance, followed by Bonferroni's correction, was performed. P values Ͻ0.05 were considered significant.
Results
BK stimulated IP3 formation on cardiomyocytes of the neonatal rat in a dose-dependent manner. IP3 increased from a basal level of 75.2 Ϯ 7.6 to the maximum of 770.3 Ϯ 22.7 pmol/mg protein at extracellular Ca 2ϩ concentrations of 0.5 mmol/L (Figure 1 ). Figure 2 shows the effect of ketamine on BKinduced IP3 production with various concentrations of extracellular calcium. IP3 production increased significantly from 429. (Figure 3) . However, the increase in intracellular calcium with 1 mol/L A23187 did not significantly affect IP3 production decreased by ketamine. A23187 10 mol/L increased basal IP3 production ( Figure 4) .
We studied the effect of ketamine on IP3 production during treatment with nicardipine and verapamil (voltage-dependent Ca 2ϩ channel blocker), but we did not find that nicardipine and verapamil affected IP3 production in the presence and absence of ketamine ( Figure 5 ).
W-7 1 mol/L had no effect on basal or BK-induced IP3 formation, nor did it affect IP3 production in the presence of ketamine ( Figure 6 ).
Discussion
We observed that BK-induced IP3 production stimulated by extracellular Ca 2ϩ in a dose-dependent manner was significantly inhibited by ketamine. An increase in extracellular Ca 2ϩ activates the ventricular contractile state (14) . The increase in contractile activity is associated with IP3 formation (8) . BK releases IP3 through PLC, which is activated by cell-surface receptors, including GTP-binding protein (G protein), and leads to hydrolysis of phosphatidyl inositol 4,5-bisphosphate (PIP2) and release of IP3, which increase intracellular Ca 2ϩ (15 (16) . The activation of the calcium ion-sensing receptor is also found with BK (17) . Thus, our results suggest that ketamine attenuates IP3 production through the inhibition of the calcium ion-sensing receptor, G protein, or PLC. IP3 elicits a rapid release of calcium from intracellular stores and causes a positive inotropic effect in the heart. An increase in IP3 production correlates well with the increase in force of contraction.
In the present study, we showed that IP3 production is decreased by approximately 12% in the presence of 1 mmol/L ketamine. Schmitz et al. (4) demonstrated that an increase in IP3 by approximately 10% increases the force of contraction by approximately 10%-50%. Whether ketamine has negative inotropic effects in myocardium is controversial. Kanaya et al. (25) reported that ketamine inhibited contraction in ventricular myocytes, but the effect occurred at supraclinical concentrations. However, the inhibition by ketamine was prominent in a high concentration of extracellular Ca 2ϩ . IP3 production was decreased by approximately 19% in the presence of 10 mmol/L ketamine. The hypercalcemic state is often encountered in myocardial protection during cardiopulmonary bypass or in primary hyperparathyroidism. Therefore, in the hypercalcemic state, contractile activity inhibited by ketamine may be more prominent.
Intracellular Ca 2ϩ concentration can control IP3-mediated Ca 2ϩ release (18) . IP3 production by agonists are stimulated depending on the concentration of intracellular Ca 2ϩ (18) . Thus, it is possible that a concentration of intracellular Ca 2ϩ diminished by ketamine leads to decreased IP3 production. Ketamine interferes with the trancemembrane influx of Ca 2ϩ and release of Ca 2ϩ from the intracellular store, resulting in decreased intracellular Ca 2ϩ concentrations (19). Rusy et al. (2) showed that ketamine inhibits only the transmembrane influx of Ca 2ϩ without affecting release from the intracellular store and contributes to decreasing intracellular Ca 2ϩ concentrations. Ketamine inhibits transsarcolemmal Ca 2ϩ influx through L-type voltage-dependent Ca 2ϩ channels (9) . However, we did not find that nicardipine and verapamil affect IP3 formation inhibited by ketamine. The link between IP3 and the voltage-dependent Ca 2ϩ channel remains unclear. IP3 elicits a rapid release of calcium from the intracellular store. On the contrary, L-type voltage-gated channels are the main channel for slow and sustained calcium ion entry across the plasma membrane. These two phases of Ca 2ϩ release from intracellular Ca 2ϩ stores and Ca 2ϩ entry across the plasma membrane are dependent on receptor-stimulated PIP2 as the same substrate as IP3 (20) . Voltage-dependent Ca 2ϩ channel is stimulated by IP3 (20) ; however, L-type Ca 2ϩ channel blockers do not affect IP3 (5, 15) . These findings support the idea that IP3 formation suppressed by ketamine would not emanate from its inhibition of the voltage-gated Ca 2ϩ channel. We demonstrated that TMB-8, an intracellular Ca 2ϩ inhibitor, enhanced ketamine inhibition of IP3 production; however, increases of intracellular Ca 2ϩ with A23187 could not block IP3 production inhibited by ketamine. This result suggests one possibility that inhibition of IP3 production by ketamine would not be associated with the concentration of intracellular Ca 2ϩ . Reduced release of Ca 2ϩ from SR is believed to be essential in the negative inotropic action of ketamine (2). Riou et al. (19) reported that the function of SR is impaired by ketamine; however, the concentration of ketamine in their study was 100 mol/L, which is 10 -100 times higher than that used clinically. Connelly et al. (21) demonstrated that a clinical concentration of ketamine does not alter Ca 2ϩ release from cardiac SR. In this study, we showed that a decrease in IP3 production by ketamine is mediated at the clinical concentration of ketamine. Therefore, the negative inotropic action of ketamine may be associated with the inhibition of the fast increase of Ca 2ϩ from SR. Calmodulin also has a regulatory role in Ca 2ϩ release from SR. The protein could reduce rapid Ca 2ϩ released by IP3 by decreasing the duration of Ca 2ϩ channel open events in the rat heart (22) . Therefore, we investigated whether calmodulin is associated with IP3 production or whether ketamine affects calmodulin. W-7 has been reported to increase Ca 2ϩ release from the SR by interfering with the binding between the calmodulin receptor and the Ca 2ϩ -calmodulin complex (22) . However, in the present study, we showed that W-7 does not affect IP3 production in the presence and absence of ketamine. Halothane and isoflurane have been reported to alter the Ca 2ϩ -binding affinity of calmodulin and to weakly reduce the activity of myosin light chain kinase (23) . Our result indicates that calmodulin is not involved in the decrease in IP3 production by ketamine.
Neonatal myocardium is more sensitive than adult myocardium to extracellular calcium concentrations. This is associated with poorly developed sarcoplasmic reticulum of neonatal myocardium (24) . Thus, contractile activity in neonatal myocardium seems to be dependent on the entry of extracellular Ca 2ϩ , rather than the release of Ca 2ϩ from SR. IP3-induced Ca 2ϩ release from SR may play a less important role in contractile activity compared with adult myocardium.
In conclusion, ketamine inhibits the BK-induced IP3 formation depending on the extracellular Ca 2ϩ concentrations. The IP3 formation reduced by ketamine would be associated with the inhibition of the calcium ion sensing receptor, G protein, or PLC, rather than alteration of intracellular Ca 2ϩ concentrations.
